2002
DOI: 10.1016/s1695-4033(02)78709-2
|View full text |Cite
|
Sign up to set email alerts
|

Efecto de los corticoides en el tratamiento de la distrofia muscular de Duchenne

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
0
1

Year Published

2011
2011
2013
2013

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 18 publications
0
1
0
1
Order By: Relevance
“…In the present study, we showed that monoterpenes both alone and combined have inhibitory effects on enzyme release, and their antiallergic effects were even higher than those of the antiallergic drug desloratadine. These results suggest that tested compounds could act as antiallergic drugs stabilizing membranes [27]. The passive cutaneous anaphylaxis (PCA) model is widely used in vivo to examine the antiallergic effect of compounds on immediate hypersensitivity type I reactions because it mimics an acute mast cell-mediated reaction [19].…”
Section: Discussionmentioning
confidence: 95%
“…In the present study, we showed that monoterpenes both alone and combined have inhibitory effects on enzyme release, and their antiallergic effects were even higher than those of the antiallergic drug desloratadine. These results suggest that tested compounds could act as antiallergic drugs stabilizing membranes [27]. The passive cutaneous anaphylaxis (PCA) model is widely used in vivo to examine the antiallergic effect of compounds on immediate hypersensitivity type I reactions because it mimics an acute mast cell-mediated reaction [19].…”
Section: Discussionmentioning
confidence: 95%
“…Ob-revisão servou-se que o grau funcional, de acordo com a escala de Vignos, se acentuou de maneira significativamente melhor nos pacientes em uso de esteróides que tornou os efeitos colaterais insignificantes relativamente à evolução positiva ocorrida 20 . Em outro estudo associado ao uso de corticóide, 10 crianças, de idade entre 6 e 9 anos -justamente no momento em que a progressão da doença tende levar a um maior acometimento funcional -observou-se uma maior estabilidade no quadro clínico funcional, não houve melhora na realização das funções, mas a duração de estabilidade do quadro se manteve positiva 21 .…”
Section: Discussionunclassified